Global Gastrointestinal (GI) Stent Market Size By Type (Biliary Stents, Duodenal Stents), By Application (Biliary Disease, Colorectal Cancer), By Region, And Segment Forecasts, 2023 to 2032

The Global Gastrointestinal (GI) Stent Market was valued at USD 470 million in 2023 and is projected to reach USD 812 million by 2031, growing at a CAGR of 7.0% during the forecast period of 2023–2031. The demand for GI stents is driven by the rising incidence of gastrointestinal cancers, increasing preference for minimally invasive procedures, and growing geriatric population prone to gastrointestinal disorders. These stents play a crucial role in palliative care by relieving obstruction in the digestive tract, making them vital in managing colorectal, esophageal, and biliary cancers.

Drivers:

1. Rising Prevalence of GI Cancers:

The growing global burden of gastrointestinal cancers, including esophageal, colorectal, and pancreatic cancers, is significantly driving the demand for GI stents as a palliative solution for patients experiencing malignant obstructions.

2. Technological Advancements in Stent Design:

Innovations such as self-expandable metallic stents (SEMS), biodegradable stents, and drug-eluting stents are improving patient outcomes by enhancing flexibility, biocompatibility, and anti-tumor effectiveness.

3. Minimally Invasive Procedure Preference:

GI stenting offers less trauma, faster recovery, and shorter hospital stays compared to surgical options. This aligns with the global healthcare trend toward minimally invasive treatments.

Restraints:

1. Risk of Complications and Re-obstruction:

Despite their effectiveness, GI stents may lead to complications such as migration, perforation, and re-obstruction, particularly in malignant cases, impacting physician and patient confidence.

2. Limited Access in Low-Income Countries:

High procedure and device costs restrict access to GI stenting in resource-constrained settings, especially in rural healthcare systems.

Opportunity:

1. Expanding Applications in Benign GI Disorders:

While traditionally used in malignant obstructions, GI stents are increasingly being considered for managing benign strictures, creating a new revenue stream for manufacturers.

2. Emerging Markets and Growing Healthcare Infrastructure:

Regions like Asia-Pacific, Latin America, and Africa present untapped potential due to rising healthcare investments, increased awareness, and the rapid expansion of endoscopic services.

Market by System Type Insights:

By system type, Self-expandable Metallic Stents (SEMS) accounted for the largest market share in 2023 due to their widespread use in malignant obstructions and high flexibility. These stents offer long-term patency and are preferred over plastic stents for their lower occlusion rates. Biodegradable stents are expected to grow at the fastest pace, owing to their promise of eliminating the need for stent removal procedures and reducing long-term complications.

Market by End-use Insights:

In 2023, Hospitals dominated the GI stent market, holding over 55% of the total revenue share. This is attributed to the high volume of endoscopic procedures performed in hospital settings and the availability of specialized gastroenterologists. Ambulatory Surgical Centers (ASCs) are projected to witness strong growth during the forecast period due to cost-effective care and shorter patient turnover times.

Market by Regional Insights:

North America led the market in 2023, driven by the high incidence of colorectal cancer, strong reimbursement structures, and advanced healthcare infrastructure. Asia-Pacific is projected to grow at the highest CAGR through 2031 due to rising cancer burden, increasing adoption of endoscopic procedures, and favorable government initiatives in countries like China and India.

Competitive Scenario:

Key players operating in the global GI stent market include Boston Scientific Corporation, Cook Medical, Olympus Corporation, Taewoong Medical, Becton, Dickinson and Company, Medtronic plc, CONMED Corporation, Micro-Tech (Nanjing) Co., Ltd., and ELLA-CS, s.r.o.. These companies focus on strategic product launches, technological collaborations, and geographical expansions. For instance:

In 2023, Boston Scientific launched a next-gen fully covered metal biliary stent designed for better patient comfort and ease of deployment.

In 2024, Olympus expanded its stent product line in emerging Asian markets through partnerships with local distributors.

In 2025, Cook Medical introduced a new biodegradable esophageal stent under clinical trials for benign stricture management.

Scope of Work – Global Gastrointestinal (GI) Stent Market

Report Metric Details

Market Size (2023) USD 470 million

Projected Market Size (2031) USD 812 million

CAGR (2023–2031) 7.0%

Market Segments By System Type (SEMS, Plastic, Biodegradable), By End-use (Hospitals, ASCs, Specialty Clinics), By Region

Growth Drivers Rising GI cancer prevalence, Technological innovations, Minimally invasive procedure adoption

Opportunities Expansion in benign GI disorder management, Growth in emerging healthcare markets

Key Market Developments:

2023: Boston Scientific launched its advanced biliary metal stent series in the U.S. and EU, optimized for enhanced lumen patency and precise placement.

2024: Medtronic received CE mark approval for its biodegradable colorectal stent, designed to dissolve safely without endoscopic removal.

2025: Olympus Corporation formed a distribution alliance in Southeast Asia to improve access to GI endoscopic stents.

FAQs:

1. What is the current market size of the Global Gastrointestinal (GI) Stent Market?

The market was valued at USD 470 million in 2023.

2. What is the major growth driver of the Global Gastrointestinal (GI) Stent Market?

The rising prevalence of GI cancers and increasing demand for minimally invasive treatments are the major growth drivers.

3. Which is the largest region during the forecast period in the Global Gastrointestinal (GI) Stent Market?

North America accounted for the largest market share in 2023.

4. Which segment accounted for the largest market share in the Global Gastrointestinal (GI) Stent Market?

The Self-expandable Metallic Stents (SEMS) segment led the market by system type in 2023.

5. Who are the key market players in the Global Gastrointestinal (GI) Stent Market?

Key players include Boston Scientific, Cook Medical, Olympus, Taewoong Medical, Medtronic, and Becton, Dickinson and Company.

Let me know if you'd like this in DOCX or PDF format!